Showing posts with label science. Show all posts
Showing posts with label science. Show all posts

Tuesday, October 7, 2008

Simple Precaution May Decrease Likelihood of SIDS

USA

A recent study by Kaiser Permanente indicates that using a fan to circulate air over sleeping babies decreases the likelihood of SIDS, (Sudden Infant Death Syndrome) also known as crib death. For the past several decades, doctors and scientists have struggled to discover the cause of SIDS, but thus far have only achieved a list of factors which may help prevent the tragic occurrence. Placing babies to sleep on their backs, and keeping cribs free of excessive blankets, pillows, and stuffed animals are some of the measures that have helped decrease the frequency of SIDS in the US by 56% between 1992 and 2003. Doctors theorize that the addition of a fan may help prevent SIDS by ensuring that the carbon dioxide which babies exhale as they sleep is circulated away from their faces, rather than being re-inhaled. The study indicates that the presence of a fan, in addition to the previously known preventative measures, decreases the overall changes of SIDS by 72%. Doctors stress that all the precautions must be used together to achieve the optimal result, end encourage parents to consult their pediatricians before deciding to use a fan.

Thursday, September 25, 2008

Scientists Coax Adult Cells Back to Embryonic State

Harvard University, USA

Stem cell research has been one of the most promising areas of medical advancement in our generation. Political controversy, however, has strangled funds for research projects, while moral controversy keeps the public decidedly undecided about the potentially life-saving knowledge we stand to gain. The question we are faced with, time and again, is "Is it ever acceptable to use embryonic stem cells for medical research?" Starting now, the answer may not matter.

A team of scientists at Harvard University has developed a method by which adult stem cells can be regressed back to their original embryonic state. With the controversy of harvesting true embryonic cells behind them, scientists may be able to learn by leaps and bounds in the next few years.

"We have removed a major roadblock for translating this into a clinical setting," said Konrad Hochedlinger, a Harvard University stem cell researcher whose research was published online today by the journal Science. "I think it's an important advance."

To read more, visit http://www.washingtonpost.com/wp-dyn/content/article/2008/09/25/AR2008092502099.html?hpid=moreheadlines

Tuesday, September 16, 2008

Genetic Therapy May Prevent Hereditary Blindness

Paris, France

A condition known as Leber hereditary optic neuropathy robs young adults of their sight by destroying the optic nerve. In Paris, Marisol Corral-Debrinski and her team at the Pierre and Marie Curie university have created a treatment which may be the light at the end of the tunnel for potential sufferers of the disorder.

The experimental treatment involved implanting functional copies of the ND4 gene, which is irregular in Leber patients, into lab rats with the disease. Electric impulses were used to temporarily open the cells' surface pores. Among treated rats, most of the optic nerve cells survived. Untreated rats lost 40% of their optic nerve cells within eight weeks.

Though the current treatment has only been tested in lab rats, the solution to Leber is beginning to come into focus.

To read more, visit http://www.newscientist.com/channel/health/mg19926735.000-hereditary-blindness-therapy-within-sight.html?feedId=online-news_rss20

Wednesday, September 3, 2008

New Screening Technique Better for Detecting Breast Cancer

Traditional breast cancer screening consists of monthly self-exams, yearly professional exams, and, for older or high-risk women, mammograms. With recent advances in breast cancer screening and treatment, women have a better chance of surviving the disease than ever before. Scientists and doctors are trying to increase that chance even further, and recently unveiled a new screening technique that may go on to save thousands of lives.

Molecular breast imaging (MBI) is a new technology which was presented this week at the American Society of Clinical Oncology's 2008 Breast Cancer Symposium in Washington, D.C. Unlike mammograms, MBI images the breast using a an injected radiotracter that is able to detect different behaviors between cancerous and healthy cells. In a study presented at the symposium, MBI detected 10 out of 13 cancers among 375 patients. Mammograms detected three. Together, the techniques would have detected 11.

In addition to detecting more cancers, MBI produces fewer false positives than mammograms; 28% of MBI-prompted biopsies proved to be cancerous, compared with only 28% of mammogram prompted biopsies. "Based on the results, MBI has shown great promise as a valuable adjunct to screening mammography in women with dense breasts and who are at an increased risk of developing cancer," said study author Carrie B. Hruska, a research fellow in the department of radiology at the Mayo Clinic in Rochester, Minn.

MBI technology is relatively inexpensive and easy to use. The future of the treatment depends upon it's spread across the country, as the screening is not yet widely available.

To read more, visit http://www.washingtonpost.com/wp-dyn/content/article/2008/09/03/AR2008090303193.html

Monday, August 11, 2008

Cloaking Device Within Reach

USA

If you've ever seen an episode of Star Trek, or if you payed careful attention to The Coneheads, you'll know what a cloaking device is. However, on the off chance that the Goose has any non-nerd readers, a cloaking device is something like an invisibility cloak - a special material that hides solid objects from view.

In the past, scientist have reportedly been able to hide very thin, almost 2-dimensional objects behind special materials designed to bend light in unusual ways. Today, thanks to the development of metamaterials (man-made combinations of metal and ceramic, Teflon or fiber composite) scientists have demonstrated that they can cloak 3D masses as well.

Unlike stealth technology, which makes it harder for radar to detect aircraft by minimizing cross-section, cloaking devices may one day make such objects completely invisible. Since the human eye recognizes 3D objects by the way they bend and scatter light rays, scientists have been developing metamaterials to "bend light around objects so they don't create reflections or shadows."

Find out more at http://www.foxnews.com/story/0,2933,401208,00.html

Tuesday, July 29, 2008

Drug Trial Gives Hope to Alzheimer's Sufferers

Scientists in the United Kingdom have tested a drug, called Rember, which shows tremendous promise for the treatment of Alzheimer's disease.

The illness, as many know, causes a slow deterioration of memory and cognitive function. Nicknamed "the long goodbye" by many physicians, Alzheimer's is often the hardest on those close to the patient, who are confronted with the bit-by-bit loss of the person they know and love. However, the patient must also suffer the embarrassment and pain of knowing the effects of the incurable condition, and many fear becoming a burden to their families.

That's why the promise of this new drug is so uplifting. In medical trials among 321 patients, there was an 81% difference in the rate of mental decline between those who took Rember and those who were given a placebo. According to researchers, after a 19-month period, those who took the new drug had no significant decline in mental function.

The Goose has previously reported on research pertaining to excess protein, or plaque, which builds up in the brains of Alzheimer's sufferers, and treatment focused on this plaque. Rember, technically known as methylthioninium chloride, treats instead a protein called Tau, which builds up inside the cells of the brain responsible for memory. This different angle of treatment may be responsible for Rember's apparent success.

Further trials are planned, however Rember may be available as early as 2012.

To read more about this remarkable drug, visit http://news.bbc.co.uk/2/hi/health/7525115.stm

Thursday, July 17, 2008

Argentine Scientists Devlop Tasty, Healthy Burger

La Plata, Argentina

We Americans have our own love affair with beef, to the tune of 97 lbs consumed by the average individual in 2006. Imagine then the Argentines, who each ate an average of 140 lbs! The tasty diet staple comes with a price, however. Beef's high fat content is a contributing factor to Argentina's high heart disease levels, in addition to other health problems. What's more, healthy alternatives such as soy and fish products - abundant in Argentina - are seldom on the Argentine menu.

In light of all this, scientists at the Center for Research and Development in Food Cryotechnology have spent the past two years in hot pursuit of a new ground beef burger with all the taste and none of the dangers associated with traditional patties. After hundreds of failed attempts, they've finally devised a formula so convincing that it left 40 taste testers hungry for more.

The basic process for developing the new burger was to remove the beef fat from the meat, and replace it with healthier agents such as sunflower oil and fats from seafood. It may not sound appetizing, but according to Alicia Califano, a chemist who helped develop the recipe, "The taste is very similar to a regular hamburger because the oils and fats we've added -- even the seafood oils -- are neutral in taste and smell." She went on to caution, "But if you tried to make a hamburger this lean at home, it would be really hard and dry."

The miracle burgers aren't yet available in stores, as the project's leaders must still negotiate a contract with a mass distributor.

To learn more, visit http://www.washingtonpost.com/wp-dyn/content/article/2008/07/14/AR2008071401992.html?hpid=topnews

Thanks to Papa Goose for this story!

Thursday, June 26, 2008

After 8 "Deaths," Kristy Sanderson Looks Forward to Sweet 16

15 year-old Kristy Sanderson must be part feline, because she's living her ninth life. Born with serious heart problems, she was expected to live only a few weeks. Doctors attempted open-heart surgery on the infant with disastrous results; she died a total of 8 times on the operating table. Miraculously, the surgeons were able to resuscitate baby Kristy and fit her with the world's tiniest pacemaker.

Kristy's had to have the pacemaker changed out a few times since then. And, for the rest of her life, she'll have to get a new one every 8-10 years. Still, says the teen, "There’s barely a day that goes by when I don’t think how lucky I am to be alive."

Kristy is able to lead a normal life, and is looking forward to her 16th birthday.

Read the full story at http://www.express.co.uk/posts/view/49709/Sweet-16-the-girl-who-died-8-times-as-a-baby

Monday, June 23, 2008

Scientists Discover New Piece to the Alzheimer's Puzzle

Harvard Medical School, US

For quite some time, doctors and scientists have acknowledged the presence of beta-amyloid (a sticky protein) buildup in the brains of Alzheimer's patients. What has remained unknown is whether the plaque was a cause of the disease, or merely a side effect. The fact that beta-amyloid buildup can be found in the brains of some non-Alzheimer's patients pointed to the latter.

However, in a recent study led by Dr. Ganesh M. Shankar and Dr. Dennis J. Selkoe of Harvard Medical School, rats injected with a specific form of the protein exhibited Alzheimer's symptoms. Meanwhile other rats, injected with different forms of beta-amyloid, showed no symptoms. Therefor it seems that a certain strain of beta-amyloid may in fact be a contributing cause of Alzheimer's, while other harmless strains are not.

In the constant struggle to understand this mysterious disease, such tiny clarifications are priceless. Understanding the exact cause of Alzheimer's may prove to be the key to finding a treatment, and now science is one step closer.

To find out more about the study, visit http://www.foxnews.com/story/0,2933,370002,00.html

Wednesday, June 18, 2008

Zero Pollution Motors Presents the Compressed Air Vehicle

New Paltz, NY, US

You've heard of cars that run on gasoline, cars that run on electricity, and even cars that run on corn oil. But how about cars that run on regular old air? Zero Pollution Motors and the MDI Group of France unveiled just such a vehicle at this year's X PRIZE Exhibit at an auto show in New York.

Running on compressed air, the car achieves the rough equivalent of 100 mpg, can travel at speeds over 90 miles per hour, and emits virtually no CO2. The air tank holds 3200 cubic feet of air at a pressure of 4500 pounds per square inch. A full 8-gallon tank will take you on an 848 mile trip, after which you can fill up at a specially equipped air pump for about 2$ US. If you prefer, you can buy a special air compressor separately which attaches to the vehicle and fills it for you. The six-seater air car will be held to the same standards as other family vehicles in the US, and will be available for about 17,800$ US. ZPM began taking reservations for US deliveries of the Air Car early this year, and the first models are scheduled to arrive in 2010.

To learn more, visit http://zeropollutionmotors.us/

Monday, June 16, 2008

Zero-Emission FCX Clarity Availably in July

Takanezawa, Japan

Honda has begun production of it's first zero-emission car, the FCX Clarity. Running on hydrogen and electricity, the four-seater sedan will be available to lease in California in July, and later this year in Japan. The FCX Clarity will offer twice the fuel economy of a gas-electric hybrid and three times that of a traditional gas powered car.

To learn more, visit http://www.foxnews.com/story/0,2933,367244,00.html

Friday, June 13, 2008

These Suits are Made for Walkin'

NASA has placed an order for space suits to be worn by astronauts on the new Orion capsule when it launches in 2015. Oceaneering International will design and manufacture the new suits, which will be better suited to astronauts' needs in space. The suits will allow astronauts to be real-life Transformers by swapping the rigid, protective panels of the suits (used during launch, landing, and trips to the International Space Station) for more flexible components to allow for natural movements when they're walking on the moon. Cool!

Check it out at http://space.newscientist.com/article/dn14135-nasas-new-spacesuits-are-made-for-walking.html?feedId=online-news_rss20

Thursday, June 12, 2008

The Little Tree that Could

Masada, Israel

2,000 years ago, among Roman attacks and Hebrew resistance, a date tree in Masada dropped its fruit to the ground. In 2005, scientists recovered the seeds left behind long after the dates had rotted away. In an amazing display of resilience, one of the little seeds sprouted, giving life to "Methuselah". The 4-ft tall date palm holds the record for the oldest seed to successfully grow in to a plant.

Scientist won't be able to tell whether Methuselah is a boy or a girl until the plant reaches 6 or 7 years of age, but Dr. Sarah Sallon, director of the Louis L. Borick Natural Medicine Research Center at Hadassah Medical Organization in Israel hopes to use Methuselah to restore the extinct Judean date palm to life. The ancient species was once well known not only for the fruit it bore, but also for its medicinal applications.

"Part of our project is to preserve ancient knowledge of how plants were used," says Sallon, "to domesticate them so we have a ready source of raw material."

To read more and to see Methuselah, visit http://dsc.discovery.com/news/2008/06/12/ancient-date-tree.html

Wednesday, June 11, 2008

Turning the Tables on Disease: Using Viruses to Our Advantage

Malvern, PA

The nasty thing about viruses is that they're virtually unstoppable. Other than our own immune systems, nothing really fights them off. That's why, as we all know, there's no cure for the common cold.

But what if we could turn the tables and use viruses for our own purposes? What if we could use them like microscopic soldiers to fight, say, cancer? That's exactly what Dr. Paul Hallenbeck of Neotropix is working on. His team has been testing the recently discovered Seneca Valley Virus-001 to discover whether or not it has the potential to kill tumor cells. Of course, it also has to spare healthy cells.

This idea isn't new, and anti-cancer viruses have shown promise in the past. However the Seneca Valley Virus-001 has a special advantage: it can be borne by human blood to all parts of the body. That means it has the potential to fight metastatic cancer.

Dr. Hallenbeck has tested the virus in lab rats with lung and eye tumors, with tremendously promising results.

To read more, visit http://www.sciencedaily.com/releases/2007/10/071030160940.htm

Monday, June 9, 2008

World's Fastest Supercomputer Unveiled

Los Alamos National Laboratory, US

After six years of hard work, IBM and engineers from Los Alamos National Laboratory have unveiled the world's fastest supercomputer. It's called Roadrunner. Twice as fast as the previous title holder, Roadrunner is capable of performing one thousand trillion calculations per second in a sustained exercise.

Roadrunner's primary applications will be related nuclear weapons, and will include the simulation of nuclear explosions. Said Thomas D'Agostino, head of the National Nuclear Security Administration, "The computer is a speed demon. It will allow us to solve tremendous problems." Government officials say that the computer will also be used to solve problems in civilian engineering, medicine, and science.

According to IBM's supercomputing programs vice president David Turek, the $100 million machine is ". . . a very souped up Sony PlayStation 3."

To learn more about Roadrunner, visit http://www.cnn.com/2008/TECH/06/09/fastest.computer.ap/index.html

Kind of gives us hope for our video game addicted friends, doesn't it?
-Mother Goose

Friday, June 6, 2008

Ultra Fuel Effiecient Aptera Poised for Production

Carlsbad, CA, US

If you haven't checked it out, you really need to go to http://www.aptera.com/ and behold the wonder of the Aptera.

The futuristic 3-wheeled vehicle is scheduled to hit the production line this year, and will soon be available for purchase in California for around 30,000$. The Aptera, which is Greek for "wingless flight," gets an unfathomable 300 miles per gallon of gasoline on trips about 120 miles in length. Unlike regular engines, the Aptera's plug-in electric hybrid does not have a fixed rate of gas consumption. Rather, the length of the trip (and thereby the extent of pure-electric engine run time) determines whether the Aptera gets 1000 miles per gallon (a 50-mile trip) or 300 (over 100 miles).

Though the Aptera is technically categorized as a motorcycle, the manufacturers are striving to exceed safety standards for regular passenger cars. The Aptera features air bags and a roll bar, and is already designed to exceed rollover roof strength and door strength requirements put forth by Federal Motor Vehicle Safety Standard 216.

While three-wheeled vehicles are hardly a new concept, the Aptera's design, featuring two front wheels with one behind, is the opposite of what we think of as a tricycle. This design is intended to eliminate the instability to which traditional tricycles are prone.

The Aptera is projected to exceed 85 miles per hour at maximum speed. After a day of driving, it charges simply by being plugged into a standard 110 volt outlet for 2-4 hours. The cost of charging, based on California energy data, is estimated to be 1-2$ a day.

For more information, cool videos, and pretty pictures, check out http://www.aptera.com/.

Wednesday, June 4, 2008

Synthetic Molecules Show Promise for Fighting Cancer

Hebrew University-Hadassah Medical School, Jerusalem

Prof. Shimon Gatt and Dr. Arie Dagan have developed synthetic molecules which may be the foundation for a new class of anti-cancer drugs. The molecules, mostly derivatives of ceramide, have been shown to reduce the sizes of various malignant tumors, including pancreatic, prostate, and breast tumors. The molecules inflict little to no damage on surrounding, healthy tissue.

Ceramide is a lipid molecule which causes what is called "programmed cell death" in several types of cancer cells. Its natural levels in the body are not high enough to be beneficial in fighting cancer, however the synthetic molecules developed by Prof. Gatt and Dr. Gagan increase these levels significantly.

For more information, visit http://www.sciencedaily.com/releases/2008/06/080604101546.htm